Open menu
Nanowerk

Nanotechnology Business News

The latest product and company news

RSS Subscribe to our Nanotechnology Business News feed

New Website on Piezo Technology

PI Ceramic -- a leading manufacturer of piezo ceramic materials, piezo components and custom engineered piezo products -- has released a new website.

Posted: Jul 29th, 2010

Read more

Marina Biotech Acquires RNA Delivery Assets of Novosom AG

The transaction further expands Marina's RNA delivery platform IP estate, which now includes DiLA2 delivery platform, tkRNAi (bacterial delivery platform), peptide nanoparticle delivery platform, and the SMARTICLES liposomal delivery platform.

Posted: Jul 29th, 2010

Read more

Oxford Instruments to Showcase MQC Benchtop NMR Analyzer at 240th ACS National Meeting

Oxford Instruments Magnetic Resonance, a leading supplier of low-field benchtop nuclear magnetic resonance (NMR) technology, with North American operations based in Concord, Massachusetts, announces that it will be showcasing its popular MQC analyzers at the American Chemical Society (ACS) National Exposition, August 22n - 25th, 2010 in booth #1126 at the Boston Convention and Exhibition Center, Boston, Massachusetts.

Posted: Jul 29th, 2010

Read more

NanoBusiness Talent Program Arranges High School Internships with Nanotechnology Start-ups

NanoBusiness Talent arranges paid internships for high school students with nanotechnology companies in Illinois, North Carolina and Colorado. Students selected for the program demonstrate the potential to make outstanding contributions in engineering and science careers. Past interns have gone on to some of the nation's most elite universities, including Harvard, Cal Tech and Duke University.

Posted: Jul 28th, 2010

Read more

SurModics And EGEN Partner For Feasibility Study of Controlled Release of siRNA Nanocomplexes

SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry and EGEN, Inc., a privately held biopharmaceutical company focused on developing nucleic acid (DNA and RNAi) therapeutics for the treatment of human diseases, are pleased to announce they have executed a continuation of their feasibility collaboration focused on long-term controlled release of siRNA complexes.

Posted: Jul 28th, 2010

Read more